Quick links

Secure login

Secure file transfer protocol

Register or renew user


Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944


Register a clinic

Fill out both forms, then either email or fax them to us at the contact above.

Clinic registration form
Provider agreement form

On behalf of patients

Request or update record
Patient update request

Looking for something else?

PhilaVax program info
Flat file reporting guide
More PhilaVax resources

Author: Aimee Lin

COVID Vaccine Expiration Dates With expiration dates for some Pfizer lots approaching, we would like to remind providers to be mindful about documenting Beyond Use Dates (BUD) and manufacture expiration dates. Any time you move vaccine from the ultra-low freezer/dry ice shipper to a standard freezer...

Get Your Patients Up to Date With Polio Vaccine Cases of polio, or poliomyelitis, have recently increased. There is no cure for polio, but it can be prevented with safe and effective vaccination. The CDC urges providers to offer polio vaccine to everyone who is not...

Monovalent (Original Formulation) mRNA Vaccines No Longer Authorized for Boosters An important note: Monovalent mRNA COVID-19 vaccines are NO LONGER authorized for use as boosters in people ages 12 years and older. From the FDA press release: With today’s authorization, the monovalent mRNA COVID-19 vaccines are not...

Monkeypox Testing, Treatment, and Vaccine Resources Following PDPH's information session on Wednesday, August 17, we have included the slides from our presentation and follow up resources on monkeypox testing and treatment. Information for Healthcare Providers on Obtaining and Using TPOXX (Tecovirimat) for Treatment of Monkeypox CDC, in partnership with FDA,...

Monkeypox Update: Second Doses PDPH is recommending that providers who are currently offering monkeypox vaccine to their patients and individuals at highest risk to begin offering second doses of the JYNNEOS vaccine to patients who have received their first dose intradermally. The second dose is recommended 28...

VFC & VFAAR Flu is Now Available to Order! Flu vaccine is now available to order for your VFC and VFAAR eligible patients. Visit our flu page for instructions on how to place your first order and which products are available to order now.Please note, all flu vaccine...

Bivalent Pfizer and Moderna Booster Vaccines Now Available for Ordering Providers can now sign into Philavax to place your orders. Orders are due by Wednesday at 5pm.Please note: bivalent vaccine orders will ship sometime after Labor Day. No vaccines will be delivered on Labor Day. Monday.com ordering,...

Monkeypox Inventory Update and Ordering Cadence To facilitate the transition to intradermal (ID) administration of the Jynneos Monkeypox (MPX) vaccine, please: Accept all Monkeypox inventory into your inventory location. Use this guide. Complete an inventory reconciliation titled "SubQ to ID Transition," so that we have an accurate...

Bivalent Pfizer and Moderna Boosters Are Coming On June 30, 2022, the U.S. Food and Drug Administration (FDA) advised manufacturers seeking to update their COVID-19 vaccines to add an Omicron BA.4/5 spike protein component to the current vaccine composition to create a bivalent booster vaccine. Pending...

VFAAR Flu Vaccine Available for All Adults for the 2022-2023 Season On October 15, 2021, the Centers for Disease Control and Prevention (CDC) issued a special allowance for Vaccines for Adults at Risk (VFAAR) flu administration. VFAAR flu vaccine can be administered to all adults regardless of...